- Ken Anderson, MD, briefed members of Congress and their legislative staffs on blood cancer care and research, and the importance of protecting and enhancing federal research funding.
Tags: BasicResearch, Grants, MultipleMyeloma
- The National Quality Forum and The Joint Commission will recognize Saul N. Weingart, MD, PhD, as a 2012 recipient of the annual John M. Eisenberg Patient Safety and Quality Award.
Tags: Honors, PatientSafety
- Dana-Farber and Broad Institute researchers for the first time are able to show the past, present, and future of CLL tumors.
Tags: BasicResearch, Genetics, Leukemia
- Dana-Farber scientists have demonstrated a new strategy for treating autoimmune disease that successfully blocked the development of rheumatoid arthritis in a mouse model. They say it holds promise for improved treatment of arthritis and other autoimmune disorders in people.
Tags: BasicResearch, ImmuneSystem
- What better way to say "I love you" than with a delicious and healthy meal. Chef Frank McClelland of Boston's four-star restaurant L'Espalier contributes recipes to this romantic dinner. All recipes are available in Dana-Farber's Health Library.
Tags: Nutrition, Prevention, Survivorship
- The Boston Red Sox and the Jimmy Fund, which together support adult and pediatric cancer care and research at Dana-Farber Cancer Institute, are celebrating the 60th anniversary of their historic partnership during the upcoming baseball season.
Tags: BostonRedSox, JimmyFund
- Dana-Farber/Children's Hospital Cancer Center is one of the first three institutions to be named as a Center of Excellence by Alex's Lemonade Stand Foundation.
Tags: BasicResearch, ChildhoodCancer, Grants, Honors
- Dana-Farber and Broad Institute researchers have identified two mutations that collectively occur in 71 percent of malignant melanoma tumors. These highly "recurrent" mutations may be the most common mutations in melanoma cells found to date.
Tags: BasicResearch, Genomics, Melanoma
- Scientists from Dana-Farber and the Broad Institute have identified two DNA mutations that appear to drive about 15 percent of meningiomas, a finding that could lead to the first effective drug treatments for the brain tumor.
Tags: BasicResearch, TargetedTherapy, BrainTumors
- Jane deLima Thomas, MD, a palliative care physician and associate director of the Harvard Palliative Medicine Fellowship Program at Dana-Farber Cancer Institute, is one of five U.S. physicians to receive the 2013 Hastings Center Cunniff-Dixon Physician Award.
Tags: EndOfLife, Honors
Showing 21-30 of 401 items